Management of Latent Tuberculosis Infection Based on T-SPOT.TB Assay in Patients with Hematological Malignancies

BACKGROUND AND OBJECTIVE: Patients with latent tuberculosis infection (LTBI) receiving chemotherapy for hematological malignancy (HM) are at high risk of developing active tuberculosis (TB) infection. The aim of this study is to show real-life data and results of the T-SPOT test and preventive isoni...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilicaslan, Emrah, Canoglu, Kadir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833312/
https://www.ncbi.nlm.nih.gov/pubmed/36660361
http://dx.doi.org/10.4084/MJHID.2023.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833312/
https://www.ncbi.nlm.nih.gov/pubmed/36660361
http://dx.doi.org/10.4084/MJHID.2023.003

Ejemplares similares